Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background and purpose: This study determined the correlation between uptake of the amyloid positron emission tomography (PET) imaging agent [18 F]flutemetamol and amyloid‐β measured by immunohistochemical and histochemical staining in a frontal cortical biopsy. Methods: Fifteen patients with possible normal pressure hydrocephalus (NPH) and previous brain biopsy obtained during intracranial pressure monitoring underwent [18 F]flutemetamol PET. Seven of these patients also underwent [11 C] P ittsburgh compound B (P i B) PET. [18 F]Flutemetamol and [11 C]P i B uptake was quantified using standardized uptake value ratio (SUVR) with the cerebellar cortex as a reference region. Tissue amyloid‐β was evaluated using the monoclonal antibody 4 G 8, T hioflavin‐S and B ielschowsky silver stain. Results: [18 F]Flutemetamol and [11 C]P i B SUVR s correlated with biopsy specimen amyloid‐β levels contralateral (r = 0.86, P < 0.0001; r = 0.96, P = 0.0008) and ipsilateral (r = 0.82, P = 0.0002; r = 0.87, P = 0.01) to the biopsy site. Association between cortical composite [18 F]flutemetamol SUVR s and [11 C]PiB SUVR s was highly significant (r = 0.97, P = 0.0003). Conclusions: [18 F]Flutemetamol detects brain amyloid‐β in vivo with moderate to high sensitivity and high specificity. This agent, therefore, represents a valuable new tool to study and verify the presence of amyloid‐β pathology, both in patients with possible NPH and among the wider population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Imaging β-amyloid burden in aging and dementia
Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., Cowie, T. F., Dickinson, K. L., Maruff, P., Darby, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000261919.22630.ea · Cited by 1,104
Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
Jack, C. R., Lowe, V. J., Senjem, M. L., Weigand, S. D., Kemp, B. J., Shiung, M. M., Knopman, D. S., Boeve, B. F., Klunk, W. E., Mathis, C. A., et al. (2008) · Brain · doi:10.1093/brain/awm336 · Cited by 958 · cited 1×
“This form of averaging has been used by a number of groups and provides an estimate of the overall amyloid-b load in the brain [20,21].”
MethodPost-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., Lopresti, B. J., Ziolko, S., Bi, W., Paljug, W. R., et al. (2008) · Brain · doi:10.1093/brain/awn016 · Cited by 933 · cited 1×
“The degree of [(11)C]PiB uptake in the cerebral cortex measured with positron emission tomography (PET) in living patients correlates with fibrillar amyloid-b levels in brain tissue measured subsequently at post mortem, as has been demonstrated by HC and IHC analyses of brain tissue samples [6,12].”
BackgroundSperling, R. A., Jack, C. R., Black, S. E., Frosch, M. P., Greenberg, S. M., Hyman, B. T., Scheltens, P., Carrillo, M. C., Thies, W., Bednar, M. M., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.05.2351 · Cited by 857
Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response
Golomb, J. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.6.778 · Cited by 279 · cited 1×
“Patients with NPH frequently have concomitant AD pathology [7,15,16], which has been associated with a poor response to ventriculo-peritoneal shunting [16].”
BackgroundLeinonen, V. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.noc80013 · Cited by 199 · cited 3×
“The current results are comparable with those obtained in a previous study with [(11)C]PiB [6], which served as the preliminary basis for the design of the current study.”
BackgroundResultSelf-citationAmyloid PET imaging in patients with mild cognitive impairment: A 2-year follow-up study
Koivunen, J., Scheinin, N., Virta, J. R., Aalto, S., Vahlberg, T., Någren, K., Helin, S., Parkkola, R., Viitanen, M., & Rinne, J. O. (2011) · Neurology · doi:10.1212/wnl.0b013e318212015e · Cited by 188 · cited 1×
“Similar to these studies [26,28], there was no effect observed in our study of the interval of several months between biopsy and PET scan, which is also supported by previous findings showing that the rate of amyloid-b accumulation in AD is relatively slow [29,30].”
ResultSelf-citationVemuri, P., Whitwell, J. L., Kantarci, K., Josephs, K. A., Parisi, J. E., Shiung, M. S., Knopman, D. S., Boeve, B. F., Petersen, R. C., Dickson, D. W., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.05.012 · Cited by 172
Indicators of amyloid burden in a population-based study of cognitively normal elderly
Mielke, M. M., Wiste, H. J., Weigand, S. D., Knopman, D. S., Lowe, V. J., Roberts, R. O., Geda, Y. E., Swenson-Dravis, D. M., Boeve, B. F., Senjem, M. L., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826e2696 · Cited by 163 · cited 1×
“Interestingly, the only ApoE4 homozygous as well as two out of four heterozygous had a [(18)F]flutemetamol-positive scan, which is in accordance with previous findings [25].”
ResultWolk, D. A. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.153 · Cited by 156
Cited by
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321
NAKAJIMA, M., YAMADA, S., MIYAJIMA, M., ISHII, K., KURIYAMA, N., KAZUI, H., KANEMOTO, H., SUEHIRO, T., YOSHIYAMA, K., KAMEDA, M., et al. (2021) · Neurologia medico-chirurgica · doi:10.2176/nmc.st.2020-0292 · Cited by 594
Curtis, C., Gamez, J. E., Singh, U., Sadowsky, C. H., Villena, T., Sabbagh, M. N., Beach, T. G., Duara, R., Fleisher, A. S., Frey, K. A., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.4144 · Cited by 332
“39) [0-30] 8.”
Self-citationAmyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease
Vandenberghe, R., Adamczuk, K., Dupont, P., Laere, K. V., & Chételat, G. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.03.014 · Cited by 99
“3H-PIB colocalizes with neuritic plaques and also with diffuse amyloid plaques and Aβ in the blood vessel wall (Lockhart et al., 2007), andmuch less sowith tangles (Lockhart et al., 2007) or otherβ sheets aggregates such as Lewy bodies (Lockhart et al., 2007).”
BackgroundInfluentialSalloway, S., Gamez, J. E., Singh, U., Sadowsky, C. H., Villena, T., Sabbagh, M. N., Beach, T. G., Duara, R., Fleisher, A. S., Frey, K. A., et al. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.06.001 · Cited by 87
“[23] and a good correspondence between quantitative measures of fibrillar amyloid and [(18)F]flutemetamol PET signal from normal pressure hydrocephalus patients who had cortical biopsy sampling either before or after PET imaging [27].”
Self-citation
Metadata
- Authors
- Leinonen, V., Rinne, J. O., Virtanen, K. A., Eskola, O., Rummukainen, J., Huttunen, J., von und zu Fraunberg, M., Nerg, O., Koivisto, A. M., Rinne, J., Jääskeläinen, J. E., Buckley, C., Smith, A., Jones, P. A., Sherwin, P., Farrar, G., McLain, R., Kailajärvi, M., Heurling, K., & Grachev, I. D.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2013-02-11
- Volume
- 20
- Issue
- 7
- Pages
- 1043-1052
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W2060816461
- Cited by
- 42
- References
- 12
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.